Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Beckley Psytech
Recent news which mentions Beckley Psytech
Atai Q3 Report: Strong Cash Position, Clinical Pipeline Growth
November 13, 2024
Tickers
ATAI
DMT
MDMA
NEWS
Tags
News
IntelGenx Corp/
ATAI Life Sciences
From
Benzinga
Beckley Psytech Doses First Patients With Psilocin In Trial For Treatment Of Major Depression Disorder
June 20, 2024
Tickers
NEWS
Tags
Cannabis
News
psilocin
From
Benzinga
Imperial College Scientists Dose First Patient With 5-MeO-DMT To Examine One Of The Most Potent Psychedelics' Effects On The Brain
June 03, 2024
Tickers
NEWS
Tags
5/MeO/DMT
Beckley Psytech Ltd
Benzinga
From
Benzinga
First Patient Dosed In Psychedelics Therapy Study For Treatment-Resistant Depression
April 26, 2024
Tickers
NEWS
Tags
5/MeO/DMT
Benzinga
Beckley Psytech Ltd
From
Benzinga
UK-Based Approach To Alcohol Addiction: 5-MeO-DMT Candidate Moves To Phase 2 Clinical Stage
April 05, 2023
Tags
Cannabis
News
Beckley Psytech
From
Benzinga
Phase 2 Trial For This Psychedelic, Potential Treatment For Severe Depression
December 22, 2022
Tags
Treatment Resistant Depression
News
Cannabis
From
Benzinga
Beyond Magic Mushrooms: Positive Clinical Trial For Treatment-Resistant Depression & Alcoholism
November 16, 2022
Tags
Benzinga
Clinical Data
5/MeO/DMT
From
Benzinga
Psychedelics M&A: Beckley Psytech Acquires Eleusis Therapeutics, Strengthening Drug Pipeline And R&D Team
October 24, 2022
Tags
Dr/ Charles Nichols
Cosmo Feilding Mellen
M&A
From
Benzinga
Palo Santo Closes $50M Psychedelic Therapeutics Investment Fund
October 12, 2022
Tags
News
Multidisciplinary Association for Psychedelic Studies
Daniel Goldberg
From
Benzinga
Beckley Psytech Begins Training Therapists For Phase 2 Trial With Toad Venom, 5-MeO-DMT
January 24, 2022
Tags
Benzinga
Topics
5/MeO/DMT
From
Benzinga
Psyched: Beckley Psytech Raises $80M, Diamond Therapeutics To Study Psilocybin Microdosing, Mydecine and Johns Hopkins Partner Up
August 23, 2021
Tickers
CLABF
MYCOF
SILFF
Tags
Benzinga
psychedelics
MYCOF
From
Benzinga
Beckley Psytech Reaches $100M Financing To Study 5-MeO-DMT, Psilocybin And Other Psychedelics
August 19, 2021
Tags
Benzinga
Markets
psychedelics
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.